Fatal cases after Omicron BA.1 and BA.2 infection: Results of an autopsy study

Int J Infect Dis. 2023 Mar:128:51-57. doi: 10.1016/j.ijid.2022.12.029. Epub 2022 Dec 27.

Abstract

Objectives: Omicron lineages BA.1/2 are considered to cause mild clinical courses. Nevertheless, fatal cases after those infections are recognized but little is known about risk factors.

Methods: A total of 23 full and three partial autopsies in deceased with known Omicron BA.1/2 infections have been consecutively performed. The investigations included histology, blood analyses, and molecular virus detection.

Results: COVID-19-associated diffuse alveolar damage was found in only eight cases (31%). This rate is significantly lower compared with previous studies, including non-Omicron variants, where rates between 69% and 92% were observed. Neither vaccination nor known risk factors were significantly associated with a direct cause of death by COVID-19. Only those patients who were admitted to the clinic because of COVID-19 but not for other reasons had a significant association with a direct COVID-19 -caused death (P >0.001).

Conclusion: Diffuse alveolar damage still occurred in the Omicron BA.1/BA.2 era but at a considerably lower frequency than seen with previous variants of concern. None of the known risk factors discriminated the cases with COVID-19-caused death from those that died because of a different disease. Therefore, the host's genomics might play a key role in this regard. Further studies should elucidate the existence of such a genomic risk factor.

Keywords: Autopsy; COVID-19; Cause of death; Fatal course; Omicron.

MeSH terms

  • Ambulatory Care Facilities
  • Autopsy
  • COVID-19*
  • Genomics
  • Humans
  • Research Design